HighTower Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$158K	Buy	99,870 +1,500	+2%	+$2.53K	﹤0.01%	3554
2025 Q4	$164K	Hold	98,370	–	–	﹤0.01%	3419
2025 Q3	$166K	Buy	98,370 +40,664	+70%	+$48.1K	﹤0.01%	3423
2025 Q2	$52.4K	Hold	57,706	–	–	﹤0.01%	3544
2025 Q1	$26.1K	Hold	57,706	–	–	﹤0.01%	3502
2024 Q4	$29K	Buy	57,706 +19,100	+49%	+$14K	﹤0.01%	3509
2024 Q3	$35K	Sell	38,606 -17,065	-31%	-$15.8K	﹤0.01%	3455
2024 Q2	$56K	Sell	55,671 -8,300	-13%	-$9.17K	﹤0.01%	3293
2024 Q1	$95K	Buy	63,971 +9,900	+18%	+$11.2K	﹤0.01%	3161
2023 Q4	$59K	Hold	54,071	–	–	﹤0.01%	3277
2023 Q3	$64K	Buy	54,071 +19,955	+58%	+$27.1K	﹤0.01%	3189
2023 Q2	$48K	Sell	34,116 -16,000	-32%	-$22.1K	﹤0.01%	3168
2023 Q1	$75K	Buy	50,116 +16,000	+47%	+$22.3K	﹤0.01%	2991
2022 Q4	$40K	Buy	34,116 +700	+2%	+$882	﹤0.01%	3065
2022 Q3	$37K	Hold	33,416	–	–	﹤0.01%	2918
2022 Q2	$53K	Hold	33,416	–	–	﹤0.01%	2900
2022 Q1	$51K	Hold	33,416	–	–	﹤0.01%	3067
2021 Q4	$82K	Buy	33,416 +100	+0.3%	+$234	﹤0.01%	2956
2021 Q3	$84K	Buy	33,316 +17,000	+104%	+$43.6K	﹤0.01%	2866
2021 Q2	$46K	Hold	16,316	–	–	﹤0.01%	2900
2021 Q1	$38K	Hold	16,316	–	–	﹤0.01%	2858
2020 Q4	$28K	Buy	+16,316	New	+$22.8K	﹤0.01%	2458

Other funds holding LCTX